Thomas H Lee Partners, a private equity firm investing in middle-market growth companies, has held the successful final close of its ninth flagship fund, Thomas H Lee Equity Fund IX (Fund IX), at its hard cap with USD5.6 billion in capital commitments.
Revo Capital has become Turkey’s largest VC fund to date with the final closing of its second fund at EUR90 million. Within the last three months, Revo Capital successfully finalised three exits from its first fund while closing its second fund and making three new investments. Revo Capital has received
Pembroke VCT, a venture capital trust focused on backing early-stage businesses, has invested GBP1 million in Peckwater Brands, the creator of data-driven virtual food brands, which develops delivery-only, fully-serviced food concepts to increase revenue for existing restaurants, its franchisees. Launched by co-founders Leo Bradshaw and Sam Martin in June 2020,
PAI Partners (PAI) has completed the acquisition of European Camping Group (ECG) from Carlyle, Ontario Teachers’ Pension Plan (Ontario Teachers) and Montefiore Investment (Montefiore). Headquartered in Aix-en-Provence, France, ECG operates a fleet of over 22,000 units (mostly mobile homes) across more than 310 premium campsites located in attractive destinations such
Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, has secured EUR5.4 million in financing via a flexible Convertible Notes Funding Programme (CNFP) from the Swiss investment firm Nice & Green. The flexible financing provided by this programme enables Marinomed
MIG Capital AG has sold portfolio company, Hemovent to MicroPort Surgical BV, a subsidiary of Shanghai-based MicroPort Scientific Corporation, (MicroPort) for a total purchase price of up to EUR123 million. Split between two funds MIG holds more than 27 per cent of Hemovent. Hemovent develops and manufactures Extra Corporal Lung
Mammoth Scientific, a health science and technology venture capital firm, has selected SS&C as administrator and technology partner for its inaugural USD100 million fund. The fund will provide venture capital to health science and technology companies maturing beyond seed rounds. The venture capital firm is building a proprietary platform
Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on next generation immune checkpoint targets, has closed a Series B round totalling EUR65 million. The financing was co-led by Athos Service GmbH – the Strüngmann family office – and MIG Capital AG, with participation from existing investors Wellington Partners,
Eatable Adventures has launched its first fund – the EUR50 million Eatable Evolution Fund FCR I. The vehicle will make early and growth-stage investments targeting the most disruptive startups in food and agriculture tech across Europe and Latin America. This will be the biggest fund of its kind in Spain
techspert.io, an AI technology specialist connecting businesses with experts for domain-specific industry insights, has closed a USD12 million investment round led by BGF. The volume of online data, information and misinformation is growing exponentially, as is the speed with which markets and products evolve. It is therefore increasingly challenging and
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
